Dosage compensation: The beginning and end of generalization

Nature Reviews Genetics

Volumn 8, Issue 1, 2007, Pages 47-57

  Straub, Tobias ^a   Becker, Peter B ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CONDENSIN; HELICASE; HISTONE ACETYLTRANSFERASE; RNA POLYMERASE; TRANSCRIPTION ELONGATION FACTOR; ZINC FINGER PROTEIN;

AMINO TERMINAL SEQUENCE; CHROMATIN STRUCTURE; DNA SEQUENCE; DROSOPHILA MELANOGASTER; EUKARYOTE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE SEQUENCE; GENETIC TRANSCRIPTION; HOUSEKEEPING GENE; IMMUNOPRECIPITATION; METHYLATION; MONOSOMY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; REPRODUCTION; REVIEW; RNA PROCESSING; SEX CHROMOSOME; X CHROMOSOME;

ANIMALS; CAENORHABDITIS ELEGANS; CHROMOSOMAL INSTABILITY; CHROMOSOME PAINTING; DOSAGE COMPENSATION, GENETIC; DROSOPHILA MELANOGASTER; EPIGENESIS, GENETIC; FEMALE; GENE EXPRESSION; HUMANS; MALE; MODELS, GENETIC; SEX CHROMOSOMES; X CHROMOSOME INACTIVATION;

EUKARYOTA;

EID: 33845768982     PISSN: 14710056     EISSN: 14710064     Source Type: Journal    
DOI: 10.1038/nrg2013     Document Type: Review

References (82)

1. Larsson, J. & Meller, V. H. Dosage compensation, the origin and the afterlife of sex chromosomes. Chromosome Res. 14, 417-431 (2006).
2. Khil, P. P. & Camerini-Otero, R. D. Molecular features and functional constraints in the evolution of the mammalian X chromosome. Crit. Rev. Biochem. Mol. Biol. 40, 313-330 (2005).
3. Vicoso, B. & Charlesworth, B. Evolution of the X chromosome: unusual patterns and processes. Nature Rev. Genet. 7, 645-653 (2006).
4. Lucchesi, J. C., Kelly, W. G. & Panning, B. Chromatin remodeling in dosage compensation. Annu. Rev. Genet. 39, 615-651 (2005).
5. Lucchesi, J. C. Dosage compensation in Drosophila. Annu. Rev. Genet. 7, 225-237 (1973).
6. Gupta, V. et al. Global analysis of X-chromosome dosage compensation. J. Biol. 5, 3 (2006).
7. Nguyen, D. K. & Disteche, C. M. Dosage compensation of the active X chromosome in mammals. Nature Genet. 38, 47-53 (2006). References 6 and 7 describe large-scale microarray analyses revealing that, apart from Drosophila melanogaster, upregulation of transcription from the single male X chromosome occurs in Caenorhabditis elegans and mammals.
8. Hamada, F. N., Park, P. J., Gordadze, P. R. & Kuroda, M. I. Global regulation of X chromosomal genes by the MSL complex in Drosophila melanogaster. Genes Dev. 19, 2289-2294 (2005). This study describes an expression microarray analysis which indicates that the increase in transcription of most of the X-linked genes by the MSL complex is graded rather than strictly twofold.
9. Straub, T., Gilfillan, G. D., Maier, V. K. & Becker, P. B. The Drosophila MSL complex activates the transcription of target genes. Genes Dev. 19, 2284-2288 (2005). The first study to prove the direct link between MSL binding and increased expression of specific genes.
10. Alekseyenko, A. A., Larschan, E., Lai, W. R., Park, P. J. & Kuroda, M. I. High-resolution ChIP-chip analysis reveals that the Drosophila MSL complex selectively identifies active genes on the male X chromosome. Genes Dev. 20, 848-857 (2006). A comparative ChIP-on-chip tiling array study of MSL3 binding in D. melanogaster cell lines and embryos favouring a transcription-based model of MSL complex recruitment.
11. Gilfillan, G. D. et al. Chromosome-wide gene-specific targeting of the Drosophila dosage compensation complex. Genes Dev. 20, 858-870 (2006). MSL1 and RNA Polymerase II profiling using ChIP-on-chip tiling arrays in D. melanogaster embryos. Complex combinations of degenerate sequence motifs can in part explain the MSL binding pattern.
12. Legube, G., McWeeney, S. K., Lercher, M. J. & Akhtar, A. X-chromosome-wide profiling of MSL-1 distribution and dosage compensation in Drosophila. Genes Dev. 20, 871-883 (2006). A ChiP-on-cDNA array study comparing MSL1 distribution in different developmental stages and tissues of D. melanogaster. The MSL binding pattern is stable and does not correlate with transcription.
13. Steinemann, M., Steinemann, S. & Turner, B. M. Evolution of dosage compensation. Chromosome Res. 4, 185-190 (1996).
14. Charlesworth, B. The evolution of chromosomal sex determination and dosage compensation. Curr. Biol. 6, 149-162 (1996).
15. Lyon, M. F. Gene action in the X-chromosome of the mouse (Mus musculus L.). Nature 190, 372-373 (1961).
16. Meyer, B. J. & Casson, L. P. Caenorhabditis elegans compensates for the difference in X chromosome dosage between the sexes by regulating transcript levels. Cell 47, 871-881 (1986).
17. Heard, E. & Disteche, C. M. Dosage compensation in mammals: fine-tuning the expression of the X chromosome. Genes Dev. 20, 1848-1867 (2006).
18. Chadwick, B. P. & Willard, H. F. Chromatin of the Barr body: histone and non-histone proteins associated with or excluded from the inactive X chromosome. Hum. Mol. Genet. 12, 2167-2178 (2003).
19. Mak, W. et al. Mitotically stable association of Polycomb group proteins eed and enx1 with the inactive X chromosome in trophoblast stem cells. Curr. Biol. 12, 1016-1020 (2002).
20. Costanzi, C. & Pehrson, J. R. Histone macroH2A1 is concentrated in the inactive X chromosome of female mammals. Nature 393, 599-601 (1998).
21. Mohandas, T., Sparkes, R. S. & Shapiro, L. J. Reactivation of an inactive human X chromosome: evidence for X inactivation by DNA methylation. Science 211, 393-396 (1981).
22. Dorigo, B., Schalch, T., Bystricky, K. & Richmond, T. J. Chromatin fiber folding: requirement for the histone H4 N-terminal tail. J. Mol. Biol. 327, 85-96 (2003).
23. Shogren-Knaak, M. et al. Histone H4-K16 acetylation controls chromatin structure and protein interactions. Science 311, 844-847 (2006).
24. Deuring, R. et al. The ISWI chromatin remodeling protein is required for gene expression and the maintenance of higher order chromatin structure in vivo. Mol. Cell 5, 355-365 (2000).
25. Badenhorst, P., Voas, M., Rebay, I. & Wu, C. Biological functions of the ISWI chromatin remodeling complex NURF. Genes Dev. 16, 3186-3198 (2002).
26. Corona, D. F., Clapier, C. R., Becker, P. B. & Tamkun, J. W. Modulation of ISWI function by site-specific histone acetylation. EMBO Rep. 3, 242-247 (2002).
27. Deng, H. et al. The JIL-1 kinase regulates the structure of Drosophila polytene chromosomes. Chromosoma 114, 173-182 (2005).
28. Meyer, B. J., McDonel, P., Csankovszki, G. & Ralston, E. Sex and X-chromosome-wide repression in Caenorhabditis elegans. Cold Spring Harb. Symp. Quant. Biol. 69, 71-79 (2004).
29. Chu, D. S. et al. A molecular link between gene-specific and chromosome-wide transcriptional repression. Genes Dev. 16, 796-805 (2002).
30. Bai, X., Alekseyenko, A. A. & Kuroda, M. I. Sequence-specific targeting of MSL complex regulates transcription of the roX RNA genes. EMBO J. 23, 2853-2861 (2004).
31. Rattner, B. P. & Meller, V. H. Drosophila male-specific lethal 2 protein controls sex-specific expression of the roX genes. Genetics 166, 1825-1832 (2004).
32. Straub, T. et al. Stable chromosomal association of MSL2 defines a dosage-compensated nuclear compartment. Chromosoma 114, 352-364 (2005).
33. Li, F., Parry, D. A. & Scott, M. J. The amino-terminal region of Drosophila MSL1 contains basic, glycine-rich, and leucine zipper-like motifs that promote X chromosome binding, self-association, and MSL2 binding, respectively. Mol. Cell. Biol. 25, 8913-8924 (2005).
34. Buscaino, A., Legube, G. & Akhtar, A. X-chromosome targeting and dosage compensation are mediated by distinct domains in MSL-3. EMBO Rep. 7, 531-538 (2006).
35. Morales, V. et al. Functional integration of the histone acetyltransferase MOF into the dosage compensation complex. EMBO J. 23, 2258-2268 (2004).
36. Morales, V., Regnard, C., Izzo, A., Vetter, I. & Becker, P. B. The MRG domain mediates the functional integration of MSL3 into the dosage compensation complex. Mol. Cell. Biol. 25, 5947-5954 (2005).
37. Akhtar, A. & Becker, P. B. Activation of transcription through histone H4 acetylation by MOF, an acetyltransferase essential for dosage compensation in Drosophila. Mol. Cell 5, 367-375 (2000).
38. Buscaino, A. et al. MOF-regulated acetylation of MSL-3 in the Drosophila dosage compensation complex. Mol. Cell 11, 1265-1277 (2003).
39. Smith, E. R. et al. A human protein complex homologous to the Drosophila MSL complex is responsible for the majority of histone H4 acetylation at lysine 16. Mol. Cell. Biol. 25, 9175-9188 (2005).
40. Taipale, M. et al. hMOF histone acetyltransferase is required for histone H4 lysine 16 acetylation in mammalian cells. Mol. Cell. Biol. 25, 6798-6810 (2005).
41. Gupta, A. et al. Involvement of human MOF in ATM function. Mol. Cell. Biol. 25, 5292-5305 (2005).
42. Stuckenholz, C., Meller, V. H. & Kuroda, M. I. Functional redundancy within roX1, a noncoding RNA involved in dosage compensation in Drosophila melanogaster. Genetics 164, 1003-1014 (2003).
43. Deng, X., Rattner, B. P., Souter, S. & Meller, V. H. The severity of roX1 mutations is predicted by MSL localization on the X chromosome. Mech. Dev. 122, 1094-1105 (2005).
44. Meller, V. H. Initiation of dosage compensation in Drosophila embryos depends on expression of the roX RNAs. Mech. Dev. 120, 759-767 (2003).
45. Lerach, S. et al. JIL-1 kinase, a member of the male-specific lethal (MSL) complex, is necessary for proper dosage compensation of eye pigmentation in Drosophila. Genesis 43, 213-215 (2005).
46. Ebert, A. et al. Su(var) genes regulate the balance between euchromatin and heterochromatin in Drosophila. Genes Dev. 18, 2973-2983 (2004).
47. Spierer, A., Seum, C., Delattre, M. & Spierer, P. Loss of the modifiers of variegation Su(var)3-7 or HP1 impacts male X polytene chromosome morphology and dosage compensation. J. Cell Sci. 118, 5047-5057 (2005).
48. Delattre, M., Spierer, A., Jaquet, Y. & Spierer, P. Increased expression of Drosophila Su(var)3-7 triggers Su(var)3-9-dependent heterochromatin formation. J. Cell Sci. 117, 6239-6247 (2004).
49. Mendjan, S. et al. Nuclear pore components are involved in the transcriptional regulation of dosage compensation in Drosophila. Mol. Cell 21, 811-823 (2006). The identification of novel interactors of the MOF acetyl transferase uncovers an important role for nuclear pores in D. melanogaster dosage compensation.
50. Dou, Y. et al. Physical association and coordinate function of the H3 K4 methyltransferase MLL1 and the H4 K16 acetyltransferase MOF. Cell 121, 873-885 (2005).
51. Taddei, A. et al. Nuclear pore association confers optimal expression levels for an inducible yeast gene. Nature 441, 774-778 (2006).
52. Cabal, G. G. et al. SAGA interacting factors confine sub-diffusion of transcribed genes to the nuclear envelope. Nature 441, 770-773 (2006).
53. Chaumeil, J., Le Baccon, P., Wutz, A. & Heard, E. A novel role for Xist RNA in the formation of a repressive nuclear compartment into which genes are recruited when silenced. Genes Dev. 20, 2223-2237 (2006).
54. Straub, T., Dahlsveen, I. K. & Becker, P. B. Dosage compensation in flies: mechanism, models, mystery. FEBS Lett. 579, 3258-3263 (2005).
55. Nusinow, D. A. & Panning, B. Recognition and modification of seX chromosomes. Curr. Opin. Genet. Dev. 15, 206-213 (2005).
56. Csankovszki, G., McDonel, P. & Meyer, B. J. Recruitment and spreading of the C. elegans dosage compensation complex along X chromosomes. Science 303, 1182-1185 (2004). A two-step process of binding and spreading operates to cover the worm X chromosome with DCC.
57. Heard, E. Delving into the diversity of facultative heterochromatin: the epigenetics of the inactive X chromosome. Curr. Opin. Genet. Dev. 15, 482-489 (2005).
58. Russell, L. B. Mammalian X chromosome action: inactivation limited in spread and region of origin. Science 140, 976-978 (1963).
59. Popova, B. C., Tada, T., Takagi, N., Brockdorff, N. & Nesterova, T. B. Attenuated spread of X-inactivation in an X;autosome translocation. Proc. Natl Acad. Sci. USA 103, 7706-7711 (2006).
60. Lyon, M. F. The Lyon and the LINE hypothesis. Semin. Cell Dev. Biol. 14, 313-318 (2003).
61. Carrel, L. & Willard, H. F. X-inactivation profile reveals extensive variability in X-linked gene expression in females. Nature 434, 400-404 (2005). A chromosome-wide analysis of genes that escape X-chromosome inactivation in humans. The distribution of escapers along the chromosome correlates with its evolutionary history.
62. Fagegaltier, D. & Baker, B. S. X chromosome sites autonomously recruit the dosage compensation complex in Drosophila males. PLoS Biol. 2, e341 (2004).
63. Oh, H., Bai, X., Park, Y., Bone, J. R. & Kuroda, M. I. Targeting dosage compensation to the X chromosome of Drosophila males. Cold Spring Harb. Symp. Quant. Biol. 69, 81-88 (2004).
64. Dahlsveen, I. K., Gilfillan, G. D., Shelest, V. I., Lamm, R. & Becker, P. B. Targeting determinants of dosage compensation in Drosophila. PLoS Genet. 2, e5 (2006).
65. Demakova, O. V. et al. The MSL complex levels are critical for its correct targeting to the chromosomes in Drosophila melanogaster. Chromosoma 112, 103-115 (2003).
66. Mockler, T. C. et al. Applications of DNA tiling arrays for whole-genome analysis. Genomics 85, 1-15 (2005).
67. Park, Y. et al. et al. Sequence-specific targeting of Drosophila roX genes by the MSL dosage compensation complex. Mol. Cell 11, 977-986 (2003).
68. Singh, N. D., Davis, J. C. & Petrov, D. A. Codon bias and noncoding GC content correlate negatively with recombination rate on the Drosophila X chromosome. J. Mol. Evol. 61, 315-324 (2005).
69. Sass, G. L., Pannuti, A. & Lucchesi, J. C. Male-specific lethal complex of Drosophila targets activated regions of the X chromosome for chromatin remodeling. Proc. Natl Acad. Sci. USA 100, 8287-8291 (2003). This is the only study so far that shows directly that the D. melanogaster DCC can be recruited de novo following transcription activation.
70. Saunders, A., Leighton, J. C. & Lis, J. T. Breaking barriers to transcription elongation. Nature Rev. Mol. Cell Biol. 7, 557-567 (2006).
71. Sims, R. J. 3rd, Belotserkovskaya, R. & Reinberg, D. Elongation by RNA polymerase II: the short and long of it. Genes Dev. 18, 2437-2468 (2004).
72. Kageyama, Y. et al. Association and spreading of the Drosophila dosage compensation complex from a discrete roX1 chromatin entry site. EMBO J. 20, 2236-2245 (2001).
73. Oh, H., Bone, J. R. & Kuroda, M. I. Multiple classes of MSL binding sites target dosage compensation to the X chromosome of Drosophila. Curr. Biol. 14, 481-487 (2004).
74. Kotlikova, I. V. et al. The Drosophila dosage compensation complex binds to polytene chromosomes independently of developmental changes in transcription. Genetics 172, 963-974 (2006).
75. Gu, W., Wei, X., Pannuti, A. & Lucchesi, J. C. Targeting the chromatin remodeling MSL complex of Drosophila to its sites of action on the X chromosome requires both acetyl transferase and ATPase activities. EMBO J. 19, 5202-5211 (2000).
76. Mito, Y., Henikoff, J. G. & Henikoff, S. Genome-scale profiling of histone H3.3 replacement patterns. Nature Genet. 37, 1090-1097 (2005).
77. Kristjuhan, A. & Svejstrup, J. Q. Evidence for distinct mechanisms facilitating transcript elongation through chromatin in vivo. EMBO J. 23, 4243-4252 (2004).
78. O'Sullivan, J. M. et al. Gene loops juxtapose promoters and terminators in yeast. Nature Genet. 36, 1014-1018 (2004).
79. Hagstrom, K. A. & Meyer, B. J. Condensin and cohesin: more than chromosome compactor and glue. Nature Rev. Genet. 4, 520-534 (2003).
80. Krogan, N. J. et al. COMPASS, a histone H3 (Lysine 4) methyltransferase required for telomeric silencing of gene expression. J. Biol. Chem. 277, 10753-10755 (2002).
81. Roguev, A. et al. The Saccharomyces cerevisiae Set1 complex includes an Ash2 homologue and methylates histone 3 lysine 4. EMBO J. 20, 7137-7148 (2001).
82. McDonel, P., Jans, J., Peterson, B. K. & Meyer, B. J. Clustered DNA motifs mark X chromosomes for repression by a dosage compensation complex. Nature 19 November 2006 (doi:10.1038/nature05338).